| 000 | 01668 a2200505 4500 | ||
|---|---|---|---|
| 005 | 20250514222655.0 | ||
| 264 | 0 | _c20050601 | |
| 008 | 200506s 0 0 eng d | ||
| 022 | _a0270-9139 | ||
| 024 | 7 |
_a10.1002/hep.20661 _2doi |
|
| 040 |
_aNLM _beng _cNLM |
||
| 100 | 1 | _aWirth, Stefan | |
| 245 | 0 | 0 |
_aPeginterferon alfa-2b plus ribavirin treatment in children and adolescents with chronic hepatitis C. _h[electronic resource] |
| 260 |
_bHepatology (Baltimore, Md.) _cMay 2005 |
||
| 300 |
_a1013-8 p. _bdigital |
||
| 500 | _aPublication Type: Clinical Trial; Journal Article | ||
| 650 | 0 | 4 | _aAdolescent |
| 650 | 0 | 4 |
_aAlanine Transaminase _xblood |
| 650 | 0 | 4 |
_aAntiviral Agents _xadministration & dosage |
| 650 | 0 | 4 | _aChild |
| 650 | 0 | 4 | _aChild, Preschool |
| 650 | 0 | 4 | _aDrug Therapy, Combination |
| 650 | 0 | 4 | _aFemale |
| 650 | 0 | 4 | _aGenotype |
| 650 | 0 | 4 |
_aHepacivirus _xgenetics |
| 650 | 0 | 4 |
_aHepatitis C, Chronic _xdrug therapy |
| 650 | 0 | 4 | _aHumans |
| 650 | 0 | 4 | _aInterferon alpha-2 |
| 650 | 0 | 4 |
_aInterferon-alpha _xadministration & dosage |
| 650 | 0 | 4 | _aMale |
| 650 | 0 | 4 | _aPilot Projects |
| 650 | 0 | 4 | _aPolyethylene Glycols |
| 650 | 0 | 4 | _aRecombinant Proteins |
| 650 | 0 | 4 |
_aRibavirin _xadministration & dosage |
| 650 | 0 | 4 | _aTreatment Outcome |
| 700 | 1 | _aPieper-Boustani, Heidrun | |
| 700 | 1 | _aLang, Thomas | |
| 700 | 1 | _aBallauff, Antje | |
| 700 | 1 | _aKullmer, Ulrike | |
| 700 | 1 | _aGerner, Patrick | |
| 700 | 1 | _aWintermeyer, Philip | |
| 700 | 1 | _aJenke, Andreas | |
| 773 | 0 |
_tHepatology (Baltimore, Md.) _gvol. 41 _gno. 5 _gp. 1013-8 |
|
| 856 | 4 | 0 |
_uhttps://doi.org/10.1002/hep.20661 _zAvailable from publisher's website |
| 999 |
_c15464587 _d15464587 |
||